# Medtronic to acquire wearable insulin patch maker EOFlow

Medtronic plc announced it has entered into definitive agreements to acquire EOFlow Co. Ltd., manufacturer of the EOPatch tubeless insulin delivery device.

- Type: Acquisition
- Announced: 2023-05-25
- Where: Seongnam, South Korea, South Korea
- Value: $738.0M
- Status: announced
- Products: EOPatch wearable insulin delivery device
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Medtronic plc](https://endata.com/companies/19071.md) (acquirer)
- [EOFlow](https://endata.com/companies/55385.md) (target)

## Sources

- [news.medtronic.com](https://news.medtronic.com/2023-05-25-Medtronic-to-acquire-wearable-insulin-patch-maker-EOFlow), 2023-05-25: "Our goal is to simplify diabetes management and deliver the well-established benefits of automated insulin delivery to our customers in the ways they want and need."
- [healthcare.levinassociates.com](https://healthcare.levinassociates.com/2023/05/25/medtronic-acquires-wearable-insulin-patch-maker-eoflow/), 2023-05-25: "The addition of EOFlow, together with Medtronic’s Meal Detection Technology™ algorithm and next-generation continuous glucose monitor, is expected to expand the company’s ability to address the needs of more individuals with diabetes."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.